Highlights Patients with chronic diseases are at an elevated risk of mental health issues due to COVID-19. Substantial depression, anxiety, and stress levels are reported in inflammatory bowel disease (IBD) patients during the pandemic. The rates of mental health distress in IBD patients during the COVID-19 pandemic are similar to those observed prior to the pandemic.
This Journal Watch discusses the study “Depression, anxiety, and stress among inflammatory bowel disease patients during COVID-19” from The Journal of Gastroenterology and Hepatology Foundation, January 2022. Authors: Raphael P Luber, Alexa Duff, Polychronis Pavlidis, Sailish Honap, Susanna Meade, Shuvra Ray, Simon H Anderson, Joel Mawdsley, Mark A Samaan, Peter M Irving Introduction Inflammatory bowel disease (IBD) patients, who are regularly treated with immune-modulating medications, are at higher risk of infection and…